Medical device recalls Moderate risk

Beckman Coulter Inc. recalls HDL Cholesterol Reagent (HDL 2 x 200), Catalog No. A15625. Intended for quantitative determination of HDL cholesterol i…

Recall date
April 3, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-2082-2017
FDA classification
Class II
Brand / firm
Beckman Coulter Inc.
Sold / distributed
Worldwide Distribution -- Australia, Bangladesh, Belgium, Brunei, Bulgaria, Canada, China, Colombia, Czech Republic, Egypt, Eritrea, Finland, France, Germany, Ghana, Greece, Guatemala, Hong Kong, India, Ireland, Italy, Japan, Jordan, Kuwait, Lebanon, Lithuania, Macau, Malaysia, Mayotte, Mexico, Net…

Why it was recalled

Beckman Coulter has identified the following drugs as potential sources of interference: Metamizole (Dipyrone), Sulfasalazine, and Sulfapyridine and may result in false low results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

HDL Cholesterol Reagent (HDL 2 x 200), Catalog No. A15625. Intended for quantitative determination of HDL cholesterol in the high density lipoprotein fraction of human serum or plasma.

Get recall alerts

Free email alert whenever Beckman Coulter Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Beckman Coulter Inc.